# Gut Microbiota and Tryptophan Metabolites in Parkinson's Disease

> **NCT07749261** · — · NOT_YET_RECRUITING · sponsor: **Ningxia Medical University** · enrollment: 30 (estimated)

## Conditions studied

- PARKINSON DISEASE (Disorder)

## Interventions

- **DIAGNOSTIC_TEST:** Stool Microbiome and Targeted Tryptophan Metabolite Profiling

## Key facts

- **NCT ID:** NCT07749261
- **Lead sponsor:** Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-20
- **Primary completion:** 2026-10-20
- **Final completion:** 2026-11-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749261, "Gut Microbiota and Tryptophan Metabolites in Parkinson's Disease". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07749261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
